Tessera Therapeutics banks $230M+
January 13, 2021- Share:
Tessera Therapeutics has raised more than $230 million in a Series B co-led by Alaska Permanent Fund, Altitude Life Science Ventures and SoftBank's Vision Fund 2. Based in the Boston area, the company is a developer of engineering technology designed to treat diseases by writing therapeutic messages into the human genome.
Additional Investors
- Share:
-
-
-
-